<DOC>
	<DOCNO>NCT00999895</DOCNO>
	<brief_summary>The purpose study evaluate outcome treatment switch define improvement CGI-CB scale ( Clinical Global Impression - Clinical Benefit ) .</brief_summary>
	<brief_title>A Study Evaluating Treatment Selection Outcome When Changing Antipsychotic Treatment Schizophrenic Patients</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>Diagnosis schizophrenia ( per DSMIV ) , least 6 month prior enrolment study Subjects initiate new antipsychotic treatment within precede 2 week Subjects whose prior current antipsychotic treatment consist typical atypical antipsychotic monotherapy Subjects fulfil criterion diagnosis psychiatric condition ( except schizophrenia ) , per DSMIV Axis Î™ , concomitant organic mental disorder mental retardation Substance abuse dependence ( exception nicotine dependence ) , define DSMIV criterion full remission Female subject pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Switch antipsychotic treatment</keyword>
	<keyword>Outcome evaluation</keyword>
	<keyword>monotherapy</keyword>
	<keyword>Greece</keyword>
</DOC>